Guillain-Barré syndrome in HIV-infected patients at Bobo-Dioulasso Hospital (Burkina Faso);Syndrome de Guillain-Barré chez les patients infectés par le VIH à Bobo-Dioulasso (Burkina Faso)

Revue Neurologique

Volumn 160, Issue 5 I, 2004, Pages 559-562

  Millogo, A ^a   Sawadogo, A ^a   Lankoande D ^a   Sawadogo, A B ^a  

^a Centre Hospitalier National Souro Sanou   (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADOLESCENT; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BURKINA FASO; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FACIAL NERVE PARALYSIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARAPLEGIA; PERIPHERAL NEUROPATHY; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; QUADRIPLEGIA; SEX RATIO;

EID: 2942726447     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(04)70986-8     Document Type: Article

References (27)

1. AHMED S, LIBMAN R, WESSON K, AHMED F, EINBERG K. (2000). Guillain-Barré syndrome: an unusual presentation of West Nile virus infection. Neurology, 55: 144-146.
2. ANONYME. (1999). Atelier national de consensus: prise en charge de l'infection à VIH: stratégies d'utilisation des antirétroviraux au Burkina Faso, traitement des infections opportunistes. Ouagadougou, mars 1999, 13p.
3. ASBURY AK, CORNBLATH DR. (1990). Assessment of current diagnostic criteria of Guillain-Barré syndrome. Ann Neurol, 27: 21-24.
4. BAHEMUKA M. (1988). Guillain-Barré syndrome in Kenya: a clinical review of 54 patients. J Neurol, 235: 418-421.
5. BEALE EO, MILLER MT. (1985). The Guillain-Barré syndrome. A review of admissions to an intensive care unit over 8 years. S Afr Med J, 67: 10-12.
6. BENYAHMED S, TURKI I, GOUIDER-KHOUJA N, et al. (2000). Polyradiculonévrites aiguës. Expérience de l'Institut National de Neurologie. Rev Neurol (Paris), 158: Abstract J5.
7. BOUCQUEY D, SINDIC CJ, LAMY M, DELMEE M, TOMASI JP, LATERRE EC. (1991). Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome. J Neurol Sci, 104: 56-63.
8. CHINYANGA HM, DANHA RF. (1992). Human immunodeficiency virus and Guillain-Barré syndrome in intensive care unit patients. Centr Afr J Med, 38: 86-88.
9. COSTE S, DE GRESLAN T, RENARD JL, BEQUET D, FELTEN D. (2002). Polyradiculonévrite aiguë secondaire à une infection à Chlamydia pneumoniae. Rev Neurol (Paris), 158: 361-363.
10. DALAKAS MC, CUPLER EJ. (1996). Neuropathies in HIV infection. Baillieres Clin Neurol, 5: 199-218.
11. DE GASPERI R, ANGEL M, SOSA G, et al. (1996). Intrathecal synthesis of anti-sulfatide IgG is associated with peripheral nerve disease in acquired immunodeficiency syndrome. AIDS Res Hum Retroviruses, 12: 205-211.
12. FEKI I, MAALEJ L, CHOYAKH F, TRIKI C, ZOUARI M, MHIRI C. (2002). Polyradiculonévrites aiguës: étude de 40 cas. Rev Neurol (Paris), 158: Abstract J11.
13. GENY C, GHERARD R, GRAY F. (1996). Complications neurologiques de l'infection à VIH. In: Serratrice G, Autret A. Neurologie. Ellipses (Paris): pp. 438-448.
14. HOWLETT WP, VEDELER CA, NYLAND H, AARLI JA. (1996). Guillain-Barré syndrome in northern Tanzania: a comparison of epidemiological and clinical findings with western Norway. Acta Neurol Scand, 93: 44-49.
15. JACOBS BC, ROTHBARTH PH, VAN DER MECHE FG, et al. (1998). The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology, 51: 1110-1115.
16. KATLAMA C. (2001). Atteintes neurologiques. In: Girard P-M, Katlama C, Pialoux G. VIH. Doin Editeurs (Paris), pp. 97-112.
17. LASTOVICA AJ, GODDARD EA, ARGENT AC. (1997). Guillain-Barre syndrome in South Africa associated with Campylobacterjejuni O:41 strains. J Infect Dis, 176: 139-143.
18. LYU RK, TANG LM, CHENG SY, HSU WC, CHEN ST. (1997). Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry, 63: 494-500.
19. MEIER PA, STEPHAN KT, BLATT SP. (1996). Cytomegalovirus polyradiculopathy in HIV-infected patients. J Gen Intern Med, 11: 47-49.
20. MILLER RF, FOX JD, THOMAS P, et al. (1996). Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J Neurol Neurosurg Psychiatry, 61: 456-460.
21. MILLOGO A, KI-ZERBO GA, SAWADOGO AB, et al. (1999). Manifestations neurologiques associées à l'infection par le VIH au Centre hospitalier de Bobo-Dioulasso (Burkina Faso). Bull Soc Pathol Exot, 92: 23-26.
22. ORLIKOWSKI D, MASSON F, SIVANO-TARDY V, et al. (2002). Prévalence des infections à Campylobacter jejuni au cours du syndrome de Guillain-Barré. Rev Neurol (Paris), 158: Abstract J28.
23. PETRATOS S, GONZALES ME. (2000). Can antiglycolipid antibodies present in HIV-infected individuals induce immune demyelination? Neuropathology, 20: 257-272.
24. RADZWILLA J, KUNTZER T, STECK AJ. (2002). Mécanismes immunitaires et traitement du syndrome de Guillain-Barré et des polyradiculoné vrites inflammatoires chroniques. Rev Neurol (Paris), 158: 301-310.
25. SAID G, LACROIX C, CHEMOUILLI P. (1991). Les neuropathies périphériques au cours de l'infection par le VIH. In SAID G, SAIMOT AG. Manifestations neurologiques et infections rétrovirales. Sida et autres rétroviroses. Pradel Editions (Paris), pp. 123-143.
26. THORNTON CA, LATIF AS, EMMANUEL JC. (1991). Guillain-Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe. Neurology, 41: 812-815.
27. VERMA A. (2001). Epidemiology and clinical features of HIV1-associated neuropathies. J Peripher Nerv Syst, 6: 8-13.